866-997-4948(US-Canada Toll Free)

Published on : Aug 31, 2015

The numerous products under development in the artificial pancreas market are studied by stage of development, regulatory path, territory, and estimated approval date. This has been presented with the help of tables and figures that provide a quantitative as well as qualitative evaluation of the data. Aspects such as product description, collaboration details, licensing information, and other developmental activities have also been highlighted in the market study.

The competitive landscape section of the report is a significant feature that reviews the performance of clinical trials conducted by leading companies and the various forces contributing toward the success of these trials.

The companies studied in the artificial pancreas market report are Converge Biotech, Inc., Schneider Children's Medical Center of Israel, University of Virginia, Rensselaer Polytechnic Institute, Covalor Medical, LLC, TecMed, Inc., University of Florida, Universitat Politecnica de Valencia, BioTex, Inc., Diabeloop, Miromatrix Medical Inc., Bigfoot Biomedical, Inc., Medtronic plc, Boston University, PharmaCyte Biotech, Inc., The University of Newcastle, Animas Corporation, Ultradian Diagnostics LLC, Pacific Diabetes Technologies, Inc., Beta-O2 Technologies Ltd., De Montfort University, University of California, Santa Barbara, Universidad Autonoma de Madrid, Cerco Medical, ViaCyte, Inc., XERIS Pharmaceuticals, Inc., Imperial College London, Advanced Biosensors-Ohio, Llc, Kencak LLC, University of California, San Francisco, Pancreum, LLC, Defymed, Inreda Diabetic BV, Dose Safety Inc., and University of Cambridge.

The overview of each of the abovementioned companies as well as of their pipeline products and ongoing clinical trials is discussed in the research report.

To request a sample copy with TOC of this report, click the link below: http://www.researchmoz.us/artificial-pancreas-pipeline-review-2015-report.html

The “Artificial Pancreas - Pipeline Review, 2015” research report is designed to help readers collate important competitor information, analyze the available data, and gain insights to improve their research and development strategies. The report aims to help the reader in identifying emerging and potential players with a strong product portfolio and devise effective counter-strategies to acquire a competitive edge. With the help of this report, readers will be able to highlight as well as understand important types of artificial pancreas under development.

By studying the present stage of product development, territory, and estimated date of launch, the readers will be able to formulate market entry and market expansion strategies and plan effective mergers and acquisitions by selecting players with the most lucrative pipeline.

To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on sales@researchmoz.us